Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1150311-17-3

C26H33Cl3N4O2Si is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1150311-17-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1150311-17-3 Structure

  • Basic information

    1. Product Name: C26H33Cl3N4O2Si
    2. Synonyms: C26H33Cl3N4O2Si
    3. CAS NO:1150311-17-3
    4. Molecular Formula:
    5. Molecular Weight: 568.018
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1150311-17-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C26H33Cl3N4O2Si(CAS DataBase Reference)
    10. NIST Chemistry Reference: C26H33Cl3N4O2Si(1150311-17-3)
    11. EPA Substance Registry System: C26H33Cl3N4O2Si(1150311-17-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1150311-17-3(Hazardous Substances Data)

1150311-17-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1150311-17-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,0,3,1 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1150311-17:
(9*1)+(8*1)+(7*5)+(6*0)+(5*3)+(4*1)+(3*1)+(2*1)+(1*7)=83
83 % 10 = 3
So 1150311-17-3 is a valid CAS Registry Number.

1150311-17-3Upstream product

1150311-17-3Relevant articles and documents

Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands

Lee, Suk Ho,Seo, Hee Jeong,Kim, Min Ju,Kang, Suk Youn,Song, Kwang-Seop,Lee, Sung-Han,Jung, Myung Eun,Kim, Jeongmin,Lee, Jinhwa

scheme or table, p. 1899 - 1902 (2009/11/30)

Cannabinoid CB-1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and obesity-related metabolic disorders were reported in 2001. To further evaluate the properties of

Pentacycle derivatives as cannabinoid CB1 receptor ligands

Lee, Suk Ho,Seo, Hee Jeong,Kim, Min Ju,Kang, Suk Youn,Lee, Sung-Han,Ahn, Kwangwoo,Lee, MinWoo,Han, Ho-Kyun,Kim, Jeongmin,Lee, Jinhwa

scheme or table, p. 6632 - 6636 (2010/06/12)

Cannabinoid CB-1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and obesity-related metabolic disorders were reported in 2001. To further evaluate the properties of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1150311-17-3